Source: Medical Device Network

Medtronic: Medtronic reports late-breaking data from TAVR system trial for aortic stenosis

Medtronic has reported late-breaking data from the Evolut Low Risk Trial's five-year outcomes of the Evolut TAVR system. The post Medtronic reports late-breaking data from TAVR system trial for aortic stenosis appeared first on Medical Device Network.

Read full article »
Annual Revenue
$10-50B
Employees
50-100K
Geoffrey S. Martha's photo - Chairman & CEO of Medtronic

Chairman & CEO

Geoffrey S. Martha

CEO Approval Rating

70/100

Read more